Microglial Activation and Chronic Neurodegeneration
Tóm tắt
Từ khóa
Tài liệu tham khảo
Block, 2007, Chronic microglial activation and progressive dopaminergic neurotoxicity, Biochem Soc Trans, 35, 1127, 10.1042/BST0351127
del Rio-Hortega, 1932
Morris, 1991, Macrophages in haemopoietic and other tissues of the developing mouse detected by the monoclonal antibody F4/80, Development, 112, 517, 10.1242/dev.112.2.517
Alliot, 1999, Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain, Brain Res Dev Brain Res, 117, 145, 10.1016/S0165-3806(99)00113-3
Rezaie, 2002, Motility and ramification of human fetal microglia in culture: an investigation using time-lapse video microscopy and image analysis, Exp Cell Res, 274, 68, 10.1006/excr.2001.5431
Ling, 1993, The origin and nature of ramified and amoeboid microglia: a historical review and current concepts, Glia, 7, 9, 10.1002/glia.440070105
Dalmau, 2003, Dynamics of microglia in the developing rat brain, J Comp Neurol, 458, 144, 10.1002/cne.10572
Soulet, 2008, Bone-marrow-derived microglia: myth or reality?, Curr Opin Pharmacol, 8, 508, 10.1016/j.coph.2008.04.002
Mildner, 2007, Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions, Nat Neurosci, 10, 1544, 10.1038/nn2015
Geissmann, 2003, Blood monocytes consist of two principal subsets with distinct migratory properties, Immunity, 19, 71, 10.1016/S1074-7613(03)00174-2
Flugel, 2001, Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy, J Neurosci Res, 66, 74, 10.1002/jnr.1198
Hickey, 1988, Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo, Science, 239, 290, 10.1126/science.3276004
Streit, 1989, Expression of Ia antigen on perivascular and microglial cells after sublethal and lethal motor neuron injury, Exp Neurol, 105, 115, 10.1016/0014-4886(89)90111-8
Shechter, 2009, Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice, PLoS Med, 6, e1000113, 10.1371/journal.pmed.1000113
Lawson, 1992, Turnover of resident microglia in the normal adult mouse brain, Neuroscience, 48, 405, 10.1016/0306-4522(92)90500-2
Ajami, 2007, Local self-renewal can sustain CNS microglia maintenance and function throughout adult life, Nat Neurosci, 10, 1538, 10.1038/nn2014
Alliot, 1991, Microglial progenitors with a high proliferative potential in the embryonic and adult mouse brain, Proc Natl Acad Sci U S A, 88, 1541, 10.1073/pnas.88.4.1541
Adams, 2007, The fibrin-derived gamma377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease, J Exp Med, 204, 571, 10.1084/jem.20061931
Hoek, 2000, Down-regulation of the macrophage lineage through interaction with OX2 (CD200), Science, 290, 1768, 10.1126/science.290.5497.1768
Harrison, 1998, Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia, Proc Natl Acad Sci U S A, 95, 10896, 10.1073/pnas.95.18.10896
Lawson, 1990, Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain, Neuroscience, 39, 151, 10.1016/0306-4522(90)90229-W
Davalos, 2005, ATP mediates rapid microglial response to local brain injury in vivo, Nat Neurosci, 8, 752, 10.1038/nn1472
Nimmerjahn, 2005, Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo, Science, 308, 1314, 10.1126/science.1110647
Kreutzberg, 1996, Microglia: a sensor for pathological events in the CNS, Trends Neurosci, 19, 312, 10.1016/0166-2236(96)10049-7
Graeber, 1988, Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells, J Neurosci Res, 21, 18, 10.1002/jnr.490210104
Colton, 1987, Production of superoxide anions by a CNS macrophage, the microglia, FEBS Lett, 223, 284, 10.1016/0014-5793(87)80305-8
Hurley, 1999, Cytokine transcripts expressed by microglia in vitro are not expressed by ameboid microglia of the developing rat central nervous system, Glia, 25, 304, 10.1002/(SICI)1098-1136(19990201)25:3<304::AID-GLIA10>3.0.CO;2-W
Si, 2002, Vpr- and Nef-dependent induction of RANTES/CCL5 in microglial cells, Virology, 301, 342, 10.1006/viro.2002.1613
Liu, 2003, Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention, J Pharmacol Exp Ther, 304, 1, 10.1124/jpet.102.035048
Lynch, 2009, The multifaceted profile of activated microglia, Mol Neurobiol, 40, 139, 10.1007/s12035-009-8077-9
Elkabes, 1996, Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function, J Neurosci, 16, 2508, 10.1523/JNEUROSCI.16-08-02508.1996
Blinzinger, 1968, Displacement of synaptic terminals from regenerating motoneurons by microglial cells, Z Zellforsch Mikrosk Anat, 85, 145, 10.1007/BF00325030
Zhong, 2010, The direction of synaptic plasticity mediated by C-fibers in spinal dorsal horn is decided by Src-family kinases in microglia: the role of tumor necrosis factor-alpha, Brain Behav Immun, 24, 874, 10.1016/j.bbi.2010.01.007
Batchelor, 1999, Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor, J Neurosci, 19, 1708, 10.1523/JNEUROSCI.19-05-01708.1999
Batchelor, 2002, Macrophages and microglia produce local trophic gradients that stimulate axonal sprouting toward but not beyond the wound edge, Mol Cell Neurosci, 21, 436, 10.1006/mcne.2002.1185
Yamada, 2008, Reduced synaptic activity precedes synaptic stripping in vagal motoneurons after axotomy, Glia, 56, 1448, 10.1002/glia.20711
Trapp, 2007, Evidence for synaptic stripping by cortical microglia, Glia, 55, 360, 10.1002/glia.20462
Siskova, 2009, Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping, Am J Pathol, 175, 1610, 10.2353/ajpath.2009.090372
Liao, 2005, Tenascin-R plays a role in neuroprotection via its distinct domains that coordinate to modulate the microglia function, J Biol Chem, 280, 8316, 10.1074/jbc.M412730200
Morgan, 2004, Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/Akt and delta-Notch signalling cascades, J Neurochem, 90, 89, 10.1111/j.1471-4159.2004.02461.x
Ransohoff, 2009, Microglial physiology: unique stimuli, specialized responses, Annu Rev Immunol, 27, 119, 10.1146/annurev.immunol.021908.132528
Block, 2005, Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism, Prog Neurobiol, 76, 77, 10.1016/j.pneurobio.2005.06.004
Graeber, 1988, The microglial cytoskeleton: vimentin is localized within activated cells in situ, J Neurocytol, 17, 573, 10.1007/BF01189811
Oehmichen, 1975, Experimental studies on kinetics and functions of monuclear phagozytes of the central nervous system, Acta Neuropathol Suppl (Berl), 285
Pei, 2007, MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity, Glia, 55, 1362, 10.1002/glia.20545
Qin, 2005, Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation, Glia, 52, 78, 10.1002/glia.20225
Qin, 2005, Microglial NADPH oxidase mediates leucine enkephalin dopaminergic neuroprotection, Ann N Y Acad Sci, 1053, 107, 10.1111/j.1749-6632.2005.tb00016.x
Wu, 2005, The role of microglia in paraquat-induced dopaminergic neurotoxicity, Antioxid Redox Signal, 7, 654, 10.1089/ars.2005.7.654
Mao, 2007, Induction of microglial reactive oxygen species production by the organochlorinated pesticide dieldrin, Brain Res, 1186, 267, 10.1016/j.brainres.2007.10.020
Mao, 2008, Synergistic microglial reactive oxygen species generation induced by pesticides lindane and dieldrin, Neuroreport, 19, 1317, 10.1097/WNR.0b013e32830b3677
Gao, 2003, Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease, J Neurosci, 23, 1228, 10.1523/JNEUROSCI.23-04-01228.2003
Bamberger, 2001, Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease, Microsc Res Tech, 54, 59, 10.1002/jemt.1121
Zhang, 2005, Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease, Faseb J, 19, 533, 10.1096/fj.04-2751com
Turchan-Cholewo, 2009, Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation, J Neurochem, 108, 202, 10.1111/j.1471-4159.2008.05756.x
Block, 2009, Air pollution: mechanisms of neuroinflammation and CNS disease, Trends Neurosci, 32, 506, 10.1016/j.tins.2009.05.009
Moss, 2001, Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function, Eur J Neurosci, 13, 529, 10.1046/j.1460-9568.2001.01418.x
Liu, 2002, Role of nitric oxide in inflammation-mediated neurodegeneration, Ann N Y Acad Sci, 962, 318, 10.1111/j.1749-6632.2002.tb04077.x
Sawada, 1989, Production of tumor necrosis factor-alpha by microglia and astrocytes in culture, Brain Res, 491, 394, 10.1016/0006-8993(89)90078-4
Lee, 1993, Cytokine production by human fetal microglia and astrocytes, J Immunol, 150, 2659, 10.4049/jimmunol.150.7.2659
Wang, 2005, MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration, Faseb J, 19, 1134, 10.1096/fj.04-2457fje
Liu, 2003, Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation, Environ Health Perspect, 111, 1065, 10.1289/ehp.6361
Olson, 2004, Characterization of cellular and neurological damage following unilateral hypoxia/ischemia, J Neurol Sci, 227, 7, 10.1016/j.jns.2004.07.021
Morioka, 1993, Characterization of microglial reaction after middle cerebral artery occlusion in rat brain, J Comp Neurol, 327, 123, 10.1002/cne.903270110
Tsuda, 2004, Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury, Glia, 45, 89, 10.1002/glia.10308
McGeer, 1988, Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains, Neurology, 38, 1285, 10.1212/WNL.38.8.1285
Ziehn, 2010, Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE, Lab Invest, 90, 774, 10.1038/labinvest.2010.6
Banati, 1995, Antibodies against microglia/brain macrophages in the cerebrospinal fluid of a patient with acute amyotrophic lateral sclerosis and presenile dementia, Clin Neuropathol, 14, 197
Hall, 1998, Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS, Glia, 23, 249, 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#
Bell, 2002, HIV and drug misuse in the Edinburgh cohort, J Acquir Immune Defic Syndr, 31, S35, 10.1097/00126334-200210012-00003
Miller, 2007, The effects of aging, injury and disease on microglial function: a case for cellular senescence, Neuron Glia Biol, 3, 245, 10.1017/S1740925X08000136
Finch, 2002, Effects of subchronic inhalation exposure of rats to emissions from a diesel engine burning soybean oil-derived biodiesel fuel, Inhal Toxicol, 14, 1017, 10.1080/08958370290084764
Yankner, 1989, Amyloid and Alzheimer's disease—cause or effect?, Neurobiol Aging, 10, 470, 10.1016/0197-4580(89)90101-2
Rogers, 1988, Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease, Neurobiol Aging, 9, 339, 10.1016/S0197-4580(88)80079-4
McGeer, 1987, Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR, Neurosci Lett, 79, 195, 10.1016/0304-3940(87)90696-3
Yankner, 1990, Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides, Science, 250, 279, 10.1126/science.2218531
Sasaki, 1997, Microglial activation in early stages of amyloid beta protein deposition, Acta Neuropathol (Berl), 94, 316, 10.1007/s004010050713
Meda, 1995, Activation of microglial cells by beta-amyloid protein and interferon-gamma, Nature, 374, 647, 10.1038/374647a0
Banati, 2000, The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity, Brain, 123, 2321, 10.1093/brain/123.11.2321
Peterson, 2001, Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions, Ann Neurol, 50, 389, 10.1002/ana.1123
Takeuchi, 2006, Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis, Neurobiol Dis, 22, 33, 10.1016/j.nbd.2005.09.014
Murphy, 2010, Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis, Brain Behav Immun, 24, 641, 10.1016/j.bbi.2010.01.014
Liu, 2006, Suppression of microglial inflammatory activity by myelin phagocytosis: role of p47-PHOX-mediated generation of reactive oxygen species, J Neurosci, 26, 12904, 10.1523/JNEUROSCI.2531-06.2006
Mack, 2003, Microglia are activated to become competent antigen presenting and effector cells in the inflammatory environment of the Theiler's virus model of multiple sclerosis, J Neuroimmunol, 144, 68, 10.1016/j.jneuroim.2003.08.032
Jordan, 1991, Infection of brain microglial cells by human immunodeficiency virus type 1 is CD4 dependent, J Virol, 65, 736, 10.1128/jvi.65.2.736-742.1991
Speth, 2005, HIV-infection of the central nervous system: the tightrope walk of innate immunity, Mol Immunol, 42, 213, 10.1016/j.molimm.2004.06.018
Brabers, 2006, Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia, Eur J Clin Invest, 36, 447, 10.1111/j.1365-2362.2006.01657.x
Turchan-Cholewo, 2009, NADPH oxidase drives cytokine and neurotoxin release from microglia and macrophages in response to HIV-Tat, Antioxid Redox Signal, 11, 193, 10.1089/ars.2008.2097
Polazzi, 2003, Neuron-conditioned media differentially affect the survival of activated or unstimulated microglia: evidence for neuronal control on apoptotic elimination of activated microglia, J Neuropathol Exp Neurol, 62, 351, 10.1093/jnen/62.4.351
McGeer, 2005, Inflammation, the complement system and the diseases of aging, Neurobiol Aging, 26, 94, 10.1016/j.neurobiolaging.2005.08.008
Block, 2007, Microglia-mediated neurotoxicity: uncovering the molecular mechanisms, Nat Rev Neurosci, 8, 57, 10.1038/nrn2038
Long-Smith, 2009, The influence of microglia on the pathogenesis of Parkinson's disease, Prog Neurobiol, 89, 277, 10.1016/j.pneurobio.2009.08.001
Boje, 1992, Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death, Brain Res, 587, 250, 10.1016/0006-8993(92)91004-X
Chao, 1992, Activated microglia mediate neuronal cell injury via a nitric oxide mechanism, J Immunol, 149, 2736, 10.4049/jimmunol.149.8.2736
Frank-Cannon, 2009, Does neuroinflammation fan the flame in neurodegenerative diseases?, Mol Neurodegener, 4, 47, 10.1186/1750-1326-4-47
McCoy, 2008, TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease, J Neuroinflammation, 5, 45, 10.1186/1742-2094-5-45
Mogi, 1994, Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients, Neurosci Lett, 165, 208, 10.1016/0304-3940(94)90746-3
Blum-Degen, 1995, Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients, Neurosci Lett, 202, 17, 10.1016/0304-3940(95)12192-7
Muller, 1998, Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease, Acta Neurol Scand, 98, 142, 10.1111/j.1600-0404.1998.tb01736.x
Nagatsu, 2000, Changes in cytokines and neurotrophins in Parkinson's disease, J Neural Transm Suppl, 60, 277
Nagatsu, 2000, Cytokines in Parkinson's disease, J Neural Transm Suppl, 58, 143
Knott, 2000, Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2, Mol Cell Neurosci, 16, 724, 10.1006/mcne.2000.0914
Sriram, 2007, Divergent roles for tumor necrosis factor-alpha in the brain, J Neuroimmune Pharmacol, 2, 140, 10.1007/s11481-007-9070-6
Sriram, 2006, Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha, Faseb J, 20, 670, 10.1096/fj.05-5106com
Sriram, 2002, Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease, Faseb J, 16, 1474, 10.1096/fj.02-0216fje
De Lella Ezcurra AL, Chertoff M, Ferrari C, Graciarena M, Pitossi F. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation. Neurobiol Dis;37:630-40.
Lee, 2009, Neuroinflammation in Parkinson's disease, J Neuroimmune Pharmacol, 4, 419, 10.1007/s11481-009-9176-0
Nimmo, 2009, Recent patents in CNS drug discovery: the management of inflammation in the central nervous system, Recent Pat CNS Drug Discov, 4, 86, 10.2174/157488909788452997
Hirsch, 2009, Neuroinflammation in Parkinson's disease: a target for neuroprotection?, Lancet Neurol, 8, 382, 10.1016/S1474-4422(09)70062-6
Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis;37:510-8.
Lee, 2008, Regulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response, J Neurosci, 28, 8517, 10.1523/JNEUROSCI.1806-08.2008
Langston, 1983, Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis, Science, 219, 979, 10.1126/science.6823561
Jackson-Lewis, 2007, Protocol for the MPTP mouse model of Parkinson's disease, Nat Protoc, 2, 141, 10.1038/nprot.2006.342
Czlonkowska, 1996, Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model, Neurodegeneration, 5, 137, 10.1006/neur.1996.0020
Kurkowska-Jastrzebska, 1999, The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse, Exp Neurol, 156, 50, 10.1006/exnr.1998.6993
Hurley, 2003, Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys, Exp Neurol, 184, 659, 10.1016/S0014-4886(03)00273-5
Barcia, 2004, Evidence of active microglia in substantia nigra pars compacta of Parkinsonian monkeys 1 year after MPTP exposure, Glia, 46, 402, 10.1002/glia.20015
Cicchetti, 2002, Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging, Eur J Neurosci, 15, 991, 10.1046/j.1460-9568.2002.01938.x
Langston, 1999, Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure, Ann Neurol, 46, 598, 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F
Hunot, 1997, Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease, Proc Natl Acad Sci U S A, 94, 7531, 10.1073/pnas.94.14.7531
Ouchi, 2009, Neuroinflammation in the living brain of Parkinson's disease, Parkinsonism Relat Disord, 15, S200, 10.1016/S1353-8020(09)70814-4
Ouchi, 2005, Microglial activation and dopamine terminal loss in early Parkinson's disease, Ann Neurol, 57, 168, 10.1002/ana.20338
Gao, 2003, Critical role for microglial NADPH oxidase in rotenone-induced degeneration of dopaminergic neurons, J Neurosci, 23, 6181, 10.1523/JNEUROSCI.23-15-06181.2003
Block, 2004, Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase, Faseb J, 18, 1618, 10.1096/fj.04-1945fje
Qin, 2002, Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species, J Neurochem, 83, 973, 10.1046/j.1471-4159.2002.01210.x
Gao, 2002, Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease, J Neurochem, 81, 1285, 10.1046/j.1471-4159.2002.00928.x
Qin, 2004, NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia, J Biol Chem, 279, 1415, 10.1074/jbc.M307657200
Paulsen CE, Carroll KS. Orchestrating redox signaling networks through regulatory cysteine switches. ACS Chem Biol;5:47-62.
Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med;48:749-62.
Nam, 2010, Co-treatment with hepatocyte growth factor and TGF-b1 enhances migration of HaCaT cells through NADPH oxidase-dependent ROS generation, Exp Mol Med, 30, 270, 10.3858/emm.2010.42.4.026
Sun, 2008, Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent activation of phosphoinositide 3-kinase and p38 mitogen-activated protein kinase signal pathways is required for lipopolysaccharide-induced microglial phagocytosis, Biol Pharm Bull, 31, 1711, 10.1248/bpb.31.1711
Roy, 2008, Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases, Free Radic Biol Med, 45, 686, 10.1016/j.freeradbiomed.2008.05.026
Wu, 2003, NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease, Proc Natl Acad Sci U S A, 100, 6145, 10.1073/pnas.0937239100
Block, 2008, NADPH oxidase as a therapeutic target in Alzheimer's disease, BMC Neurosci, 9, S8, 10.1186/1471-2202-9-S2-S8
Wu, 2005, The role of microglia in paraquat-induced dopaminergic neurotoxicity, Antioxid Redox Signal, 7, 654, 10.1089/ars.2005.7.654
Gao, 2003, Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease, FASEB J, 17, 1954, 10.1096/fj.03-0109fje
Won, 2009, Prothrombin kringle-2-induced oxidative stress contributes to the death of cortical neurons in vivo and in vitro: role of microglial NADPH oxidase, J Neuroimmunol, 214, 83, 10.1016/j.jneuroim.2009.07.005
Qian, 2009, beta2 Adrenergic receptor activation induces microglial NADPH oxidase activation and dopaminergic neurotoxicity through an ERK-dependent/protein kinase A-independent pathway, Glia, 57, 1600, 10.1002/glia.20873
Rodriguez-Pallares, 2008, Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS, Neurobiol Dis, 31, 58, 10.1016/j.nbd.2008.03.003
Hur J, Lee P, Kim MJ, Kim Y, Cho YW. Ischemia-activated microglia induces neuronal injury via activation of gp91phox NADPH oxidase. Biochem Biophys Res Commun;391:1526-30.
Green, 2001, Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation, J Cereb Blood Flow Metab, 21, 374, 10.1097/00004647-200104000-00006
Wang, 2004, Protective effect of the SOD/catalase mimetic MnTMPyP on inflammation-mediated dopaminergic neurodegeneration in mesencephalic neuronal-glial cultures, J Neuroimmunol, 147, 68, 10.1016/j.jneuroim.2003.10.040
Li, 1998, Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production, Biochem Biophys Res Commun, 253, 295, 10.1006/bbrc.1998.9729
Block, 2006, Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin, Faseb J, 20, 251, 10.1096/fj.05-4553com
Konishi, 1997, Activation of protein kinase C by tyrosine phosphorylation in response to H2O2, Proc Natl Acad Sci U S A, 94, 11233, 10.1073/pnas.94.21.11233
Guyton, 1996, Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: implications for cellular survival and tumor promotion, Cancer Res, 56, 3480
Schreck, 1991, Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1, Embo J, 10, 2247, 10.1002/j.1460-2075.1991.tb07761.x
Forman, 2002, Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling, Am J Respir Crit Care Med, 166, S4, 10.1164/rccm.2206007
Wang, 2004, Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia, J Neurochem, 88, 939, 10.1046/j.1471-4159.2003.02242.x
Min, 2004, Gangliosides activate microglia via protein kinase C and NADPH oxidase, Glia, 48, 197, 10.1002/glia.20069
Pawate, 2004, Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma, J Neurosci Res, 77, 540, 10.1002/jnr.20180
Qin, 2007, Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration, Glia, 55, 453, 10.1002/glia.20467
Gao, 2008, Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis, J Cardiovasc Pharmacol, 52, 286, 10.1097/FJC.0b013e318186a84d
Huh, 2003, Microglial activation and tyrosine hydroxylase immunoreactivity in the substantia nigral region following transient focal ischemia in rats, Neurosci Lett, 349, 63, 10.1016/S0304-3940(03)00743-2
McGeer, 2003, Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration, Ann Neurol, 54, 599, 10.1002/ana.10728
Przedborski, 2004, MPTP as a mitochondrial neurotoxic model of Parkinson's disease, J Bioenerg Biomembr, 36, 375, 10.1023/B:JOBB.0000041771.66775.d5
Wu, 2002, Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease, J Neurosci, 22, 1763, 10.1523/JNEUROSCI.22-05-01763.2002
Liberatore, 1999, Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease, Nat Med, 5, 1403, 10.1038/70978
Zhang, 2004, Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase, Faseb J, 18, 589, 10.1096/fj.03-0983fje
Feng, 2002, Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra, Neurosci Lett, 329, 354, 10.1016/S0304-3940(02)00704-8
Teismann, 2003, COX-2 and neurodegeneration in Parkinson's disease, Ann N Y Acad Sci, 991, 272, 10.1111/j.1749-6632.2003.tb07482.x
Levesque, 2010, Reactive Microgliosis: Extracellular μ Calpain and Microglia-mediated Dopaminergic Neurotoxicity, Brain, 133, 808, 10.1093/brain/awp333
Kim, 2007, A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation, Faseb J, 21, 179, 10.1096/fj.06-5865com
Zecca, 2003, Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics, Trends Neurosci, 26, 578, 10.1016/j.tins.2003.08.009
Ling, 2002, In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain, Mov Disord, 17, 116, 10.1002/mds.10078
Ling, 2006, Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally, Exp Neurol, 10.1016/j.expneurol.2006.01.010
Carvey, 2003, Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: a potential, new model of Parkinson's disease, Front Biosci, 8, s826, 10.2741/1158
Gayle, 2002, Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide, Brain Res Dev Brain Res, 133, 27, 10.1016/S0165-3806(01)00315-7
Ling, 2004, Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain, Neuroscience, 124, 619, 10.1016/j.neuroscience.2003.12.017
Niehaus, 2003, Lippopolysaccharides induce inflammation-mediated neurodeheneration in the substantia nigra and the cerebral cortex (A case report), AD/PD 6th International Conference, 1
Cunningham, 2009, Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease, Biol Psychiatry, 65, 304, 10.1016/j.biopsych.2008.07.024
Lehnardt, 2003, Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway, Proc Natl Acad Sci U S A, 100, 8514, 10.1073/pnas.1432609100
Henry, 2009, Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and anti-inflammatory IL-10 cytokines, Brain Behav Immun, 23, 309, 10.1016/j.bbi.2008.09.002
Godbout, 2005, Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system, Faseb J, 19, 1329, 10.1096/fj.05-3776fje
Gao, 2003, Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease, Faseb J, 17, 1957, 10.1096/fj.03-0203fje